Molina Healthcare, Inc $MOH Shares Sold by Renaissance Technologies LLC

Key Points

• Renaissance Technologies cut its Molina Healthcare stake by 65.6% in the first quarter, selling 42,387 shares and retaining 22,250 shares valued at approximately $2.97 million. Institutional investors collectively own 98.5% of the company.
• Analysts maintain a generally neutral outlook, with Molina receiving an average “Hold” rating and a consensus price target of $202.44. Recent targets range from $129 to $202, including an “Underweight” rating from Barclays.
• Molina reported quarterly EPS of $1.51, exceeding estimates of $1.39, while revenue reached $10.87 billion. However, revenue declined 4.8% year over year, and insiders recently sold shares; the stock opened at $196.65.

Renaissance Technologies LLC lowered its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 65.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,250 shares of the company's stock after selling 42,387 shares during the period. Renaissance Technologies LLC's holdings in Molina Healthcare were worth $2,966,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Towle & Co. purchased a new stake in Molina Healthcare during the 1st quarter worth approximately $3,713,000. Bandera Partners LLC purchased a new position in shares of Molina Healthcare during the 1st quarter valued at approximately $8,131,000. Sei Investments Co. boosted its stake in shares of Molina Healthcare by 24.5% during the 1st quarter. Sei Investments Co. now owns 67,024 shares of the company's stock valued at $8,934,000 after buying an additional 13,204 shares during the last quarter. Cetera Investment Advisers grew its position in shares of Molina Healthcare by 127.4% during the first quarter. Cetera Investment Advisers now owns 9,332 shares of the company's stock worth $1,244,000 after buying an additional 5,229 shares in the last quarter. Finally, Kopernik Global Investors LLC grew its position in shares of Molina Healthcare by 132.6% during the first quarter. Kopernik Global Investors LLC now owns 291,941 shares of the company's stock worth $38,916,000 after buying an additional 166,407 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MOH has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $129.00 price target on shares of Molina Healthcare in a report on Friday, April 24th. UBS Group raised their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a "neutral" rating in a report on Friday, May 22nd. Robert W. Baird boosted their target price on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a "neutral" rating in a research report on Monday, May 11th. JPMorgan Chase & Co. upped their target price on shares of Molina Healthcare from $169.00 to $191.00 and gave the company a "neutral" rating in a research note on Monday, June 8th. Finally, Barclays decreased their price target on Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating for the company in a research note on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $202.44.

Insider Activity at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company's stock, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm's stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This represents a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by company insiders.

Molina Healthcare Stock Up 2.5%

Shares of NYSE:MOH opened at $196.65 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The company's fifty day moving average is $209.25 and its two-hundred day moving average is $177.81. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The stock has a market capitalization of $10.27 billion, a price-to-earnings ratio of -1,092.43, a price-to-earnings-growth ratio of 28.14 and a beta of 0.75.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business's revenue was down 4.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.48 earnings per share. Equities analysts anticipate that Molina Healthcare, Inc will post 5.29 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source